Cambridge Investment Research Advisors’s ASML ASML Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$58.6M Buy
29,474
+3,147
+12% +$5.01M 0.13% 141
2026
Q1
$34.8M Buy
26,327
+3,860
+17% +$5.29M 0.09% 217
2025
Q4
$24M Buy
22,467
+760
+4% +$793K 0.06% 303
2025
Q3
$21M Buy
21,707
+334
+2% +$263K 0.06% 330
2025
Q2
$17.1M Buy
21,373
+1,772
+9% +$1.27M 0.05% 362
2025
Q1
$13M Buy
19,601
+1,394
+8% +$1.01M 0.04% 415
2024
Q4
$12.6M Sell
18,207
-833
-4% -$598K 0.04% 416
2024
Q3
$15.9M Sell
19,040
-381
-2% -$341K 0.05% 347
2024
Q2
$19.9M Buy
19,421
+374
+2% +$360K 0.07% 265
2024
Q1
$18.5M Buy
19,047
+3,441
+22% +$3.05M 0.07% 274
2023
Q4
$11.8M Buy
15,606
+1,972
+14% +$1.3M 0.05% 345
2023
Q3
$8.03M Buy
13,634
+2,833
+26% +$1.88M 0.04% 446
2023
Q2
$7.83M Buy
10,801
+1,672
+18% +$1.14M 0.04% 467
2023
Q1
$6.21M Buy
9,129
+2,681
+42% +$1.72M 0.03% 536
2022
Q4
$3.52M Buy
6,448
+172
+3% +$90.1K 0.02% 769
2022
Q3
$2.61M Sell
6,276
-126
-2% -$63.1K 0.01% 900
2022
Q2
$3.05M Buy
6,402
+1,360
+27% +$759K 0.02% 840
2022
Q1
$3.37M Sell
5,042
-1,726
-26% -$1.16M 0.02% 851
2021
Q4
$5.39M Buy
6,768
+2,480
+58% +$1.97M 0.02% 610
2021
Q3
$3.19M Buy
4,288
+411
+11% +$323K 0.02% 837
2021
Q2
$2.68M Sell
3,877
-353
-8% -$233K 0.01% 958
2021
Q1
$2.61M Buy
4,230
+493
+13% +$273K 0.01% 877
2020
Q4
$1.82M Buy
3,737
+302
+9% +$127K 0.01% 967
2020
Q3
$1.27M Buy
3,435
+1,756
+105% +$656K 0.01% 1049
2020
Q2
$618K Buy
1,679
+177
+12% +$55.6K ﹤0.01% 1432
2020
Q1
$393K Buy
1,502
+125
+9% +$35.6K ﹤0.01% 1512
2019
Q4
$407K Buy
1,377
+2
+0.1% +$540 ﹤0.01% 1711
2019
Q3
$342K Buy
1,375
+171
+14% +$38.5K ﹤0.01% 1734
2019
Q2
$250K Buy
1,204
+116
+11% +$23.1K ﹤0.01% 1866
2019
Q1
$205K Buy
+1,088
New +$193K ﹤0.01% 2056
2018
Q1
Sell
-1,371
Closed -$238K 2151
2017
Q4
$238K Buy
+1,371
New +$242K ﹤0.01% 1803

Other funds holding ASML

Cambridge Investment Research Advisors's ASML Position: Q2 2026 in Review

Cambridge Investment Research Advisors increased its ASML (ASML) stake by 12% in Q2 2026, buying an estimated $5.01M and bringing the position to 29,474 shares worth $58.6M. The position accounts for 0.13% of the portfolio, ranked #141.

Cambridge Investment Research Advisors first reported a position in ASML in Q4 2017 and has held it in 31 quarters since. 2,496 funds tracked by Wall St. Rank hold ASML as of Q2 2026.

  • Cambridge Investment Research Advisors held 29,474 shares of ASML worth $58.6M as of Q2 2026.
  • Cambridge Investment Research Advisors bought 3,147 ASML shares in Q2 2026, an estimated $5.01M.
  • ASML made up 0.13% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #141 holding.
  • Cambridge Investment Research Advisors first reported a position in ASML in Q4 2017 and has held it in 31 quarters since.
  • 2,496 funds tracked by Wall St. Rank held ASML as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.